Skip to content

Molecular and Functional Neurobiology of Physical Exercise

Molecular and Functional Neurobiology of Physical Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02615756
Acronym
EXEBRAIN
Enrollment
24
Registered
2015-11-26
Start date
2013-04-30
Completion date
2018-06-30
Last updated
2021-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Exercise Behavior (Liking/Aversion)

Brief summary

In this study, we use positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) to study brain mechanisms that contribute to physical exercise-induced reward. We examine whether acute physical exercise releases endogenous opioids in the brain, and whether it modulates brain responses to viewing appetizing foods. Unraveling these mechanism are instrumental from a public health perspective, given the undisputed positive health effects of physical exercise.

Interventions

BEHAVIORALExercise

Sponsors

Academy of Finland
CollaboratorOTHER
Novo Nordisk A/S
CollaboratorINDUSTRY
Juho Vainio Foundation
CollaboratorOTHER
University of Turku
CollaboratorOTHER
Turku University Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Native Finnish speaker 2. Age \> 18 years 3. Western Caucasian origin

Exclusion criteria

1. Age \< 18 or \> 65 2. History or current mental disorder 3. BMI \> 27 kg/m2 4. Use of drugs that influence the central nervous system, including nicotine 5. Poor compliance 6. Any chronic medical defect or injury which hinder or interfere everyday life 7. Eating disorder 8. Current or past excessive use of alcohol or substance abuse 9. Past dose of radiation from medical research such that the annual effective dose will exceed 10 mSv 10. Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results 11. Presence of any ferromagnetic objects that would make MR imaging contraindicated

Design outcomes

Primary

MeasureTime frameDescription
Binding of [11C]carfentanil in brain confirmed by positron emission tomographyBaseline and 20 min after physical exercise completionChange in binding of \[11C\]carfentanil in baseline and 20 min after physical exercise completion

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026